Introduction - Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force - NCBI Bookshelf
1 Systematic review report for Question 1b
Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System - CytoJournal
Human papillomavirus and cervical cancer - The Lancet
WO2006089287A2 - Methods for detecting progression of low grade cervical dysplasia and for detecting adenocarcinomas - Google Patents
Reporting For Cervical Biopsy Specimens – ProPath
Cervical Neoplasia and Carcinoma - Obstetrics and Gynecology 7 Ed.
Cervical Screening and HPV Testing
Colposcopic appearance of CIN (Chapter 4) - Colposcopy
Cervical Screening and the Importance of HPV Testing - CellPath
Human Papillomavirus and the Management of the Abnormal Pap Test | Obgyn Key
Figure 1, 2001 Bethesda System for the Classification of Cytology Results and Histology Classification - HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment - NCBI Bookshelf
Abnormal Pap Smears | Dr Amy Tang | Gynaecological Oncologist | Gynaecologist Brisbane
Bethesda Cervical CYtology
JaypeeDigital | eBook Reader
Abnormal cervical biopsy results | Canadian Cancer Society